FORM N-PX PROXY VOTING RECORD

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 COLUMN 9 COLUMN 10 COLUMN 11 COLUMN 12 COLUMN 13 COLUMN 14 COLUMN 15
NAME   OF   ISSUER
 CUSIP ISIN FIGI MEETING   DATE VOTE   DESCRIPTION VOTE   CATEGORY DESCRIPTION   OF   OTHER  CATEGORY VOTE   SOURCE SHARES   VOTED SHARES   ON   LOAN DETAILS   OF   VOTE MANAGER   NUMBER SERIES   ID OTHER   INFO
HOW   VOTED SHARES  VOTED FOR   OR   AGAINST   MANAGEMENT
Horizon Therapeutics Public Limited Company G46188101 IE00BQPVQZ61 - 07/27/2023 Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - - 639.000000 0 AGAINST
 639.000000
 AGAINST
 - -
Chinook Therapeutics, Inc. 16961L106 US16961L1061 - 08/02/2023 To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to Chinook's named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES
 - - 57763.000000 0 AGAINST
 57763.000000
 AGAINST
 - -
Reata Pharmaceuticals, Inc. 75615P103 US75615P1030 - 09/21/2023 To approve, on an advisory, non-binding basis, compensation that will or may be paid or become payable to Reata's named executive officers in connection with the Merger contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES
 - - 231.000000 0 AGAINST
 231.000000
 AGAINST
 - -
Consolidated Communications Holdings, Inc. 209034107 US2090341072 - 01/31/2024 To approve, by a non-binding, advisory vote, certain compensation arrangements for the Company's named executive officers in connection with the merger. SECTION 14A SAY-ON-PAY VOTES
 - - 130737.000000 0 FOR
 130737.000000
 FOR
 - -
ImmunoGen, Inc. 45253H101 US45253H1014 - 01/31/2024 A proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to ImmunoGen's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement; and SECTION 14A SAY-ON-PAY VOTES
 - - 20131.000000 0 AGAINST
 20131.000000
 AGAINST
 - -
Atmus Filtration Technologies, Inc. 04956D107 US04956D1072 - 05/14/2024 Advisory vote to approve the executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - - 13864.000000 0 FOR
 13864.000000
 FOR
 - -
Atmus Filtration Technologies, Inc. 04956D107 US04956D1072 - 05/14/2024 Advisory vote to approve the frequency of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - - 13864.000000 0 ONE YEAR
 13864.000000
 FOR
 - -
Capricor Therapeutics, Inc. 14070B309 US14070B3096 - 05/14/2024 APPROVAL OF NAMED EXECUTIVE OFFICER COMPENSATION, ON A NON-BINDING ADVISORY BASIS SECTION 14A SAY-ON-PAY VOTES
 - - 75753.000000 0 FOR
 75753.000000
 FOR
 - -
Cummins Inc. 231021106 US2310211063 - 05/14/2024 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - - 47529.000000 0 FOR
 47529.000000
 FOR
 - -
Hawaiian Holdings, Inc. 419879101 US4198791018 - 05/15/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as described in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - - 1640.000000 0 FOR
 1640.000000
 FOR
 - -
Hess Corporation 42809H107 US42809H1077 - 05/15/2024 Advisory approval of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - - 185436.000000 0 AGAINST
 185436.000000
 AGAINST
 - -
MannKind Corporation 56400P706 US56400P7069 - 05/15/2024 To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in Mannkind's proxy statement for the Annual Meeting; SECTION 14A SAY-ON-PAY VOTES
 - - 0.000000 0 - -
Repligen Corporation 759916109 US7599161095 - 05/16/2024 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - - 3715.000000 0 FOR
 3715.000000
 FOR
 - -
NextEra Energy, Inc. 65339F101 US65339F1012 - 05/23/2024 Approval, by non-binding advisory vote, of Nextera Energy's compensation of its named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES
 - - 297486.000000 84100.000000 FOR
 297486.000000
 FOR
 - -
Hess Corporation 42809H107 US42809H1077 - 05/28/2024 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Hess' named executive officers that is based on or otherwise related to the merger. SECTION 14A SAY-ON-PAY VOTES
 - - 149303.000000 0 AGAINST
 149303.000000
 AGAINST
 - -
Shockwave Medical, Inc. 82489T104 US82489T1043 - 05/29/2024 To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Shockwave's named executive officers that is based on or otherwise relates to the Merger. SECTION 14A SAY-ON-PAY VOTES
 - - 20744.000000 0 AGAINST
 20744.000000
 AGAINST
 - -
Consolidated Communications Holdings, Inc. 209034107 US2090341072 - 05/31/2024 To conduct an advisory vote on the approval of the compensation of our named executive officers (say-on-pay vote); and SECTION 14A SAY-ON-PAY VOTES
 - - 1911067.000000 0 FOR
 1911067.000000
 FOR
 - -
Gossamer Bio, Inc. 38341P102 US38341P1021 - 06/06/2024 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - - 240093.000000 388803.000000 AGAINST
 240093.000000
 AGAINST
 - -
Liberty Media Corporation 531229748 US5312297485 - 06/10/2024 The say-on-pay proposal, to approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - - 17570.000000 0 AGAINST
 17570.000000
 AGAINST
 - -
Liberty Media Corporation 531229748 US5312297485 - 06/10/2024 The say-on-frequency proposal, to approve, on an advisory basis, the frequency at which stockholders are required to provide an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - - 17570.000000 0 ONE YEAR
 17570.000000
 AGAINST
 - -
Liberty Media Corporation 531229771 US5312297717 - 06/10/2024 The say-on-pay proposal, to approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - - 109195.000000 0 AGAINST
 109195.000000
 AGAINST
 - -
Liberty Media Corporation 531229771 US5312297717 - 06/10/2024 The say-on-frequency proposal, to approve, on an advisory basis, the frequency at which stockholders are required to provide an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - - 109195.000000 0 ONE YEAR
 109195.000000
 AGAINST
 - -
IAC Inc. 44891N208 US44891N2080 - 06/11/2024 To approve a non-binding advisory vote on IAC's 2023 executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - - 390.000000 0 FOR
 390.000000
 FOR
 - -
SandRidge Energy, Inc. 80007P869 US80007P8692 - 06/12/2024 Approve, in a non-binding vote, the compensation paid to the Company's named executive officers during 2023. SECTION 14A SAY-ON-PAY VOTES
 - - 13.000000 0 FOR
 13.000000
 FOR
 - -
Nutex Health Inc. 67079U306 US67079U3068 - 06/17/2024 To vote in an advisory capacity concerning the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - - 1089765.000000 0 FOR
 1089765.000000
 FOR
 - -
HashiCorp, Inc. 418100103 US4181001037 - 06/25/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - - 9911.000000 0 AGAINST
 9911.000000
 AGAINST
 - -
Protalix BioTherapeutics, Inc. 74365A309 US74365A3095 - 06/27/2024 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement that accompanies this notice; SECTION 14A SAY-ON-PAY VOTES
 - - 1122982.000000 0 FOR
 1122982.000000
 FOR
 - -

[Repeat as Necessary]